Etiological factors of platelet damage
Coagulopathies caused by impaired thrombopoiesis represent a major problem in pathological anatomy. The development of pronounced hemorrhagic syndrome and damage to the blood platelets themselves are provoked by three main groups of factors:
- Toxic and metabolic effects. Blood cells are extremely sensitive to the chemical composition of plasma. Various medications and the toxic effects of alcohol cause their destruction. In addition, endogenous metabolites that accumulate in excess in the body during uremia and severe liver diseases act as a potent damaging factor.
- Bone marrow lesions. The normal process of cell formation is suppressed during the development of hyperplastic and metaplastic processes in the spongy bone tissue. Severe iatrogenic causes include radiation therapy and the use of cytostatic drugs, which directly suppress hematopoietic lineages.
- Mechanical damage. Platelets can undergo physical destruction directly within the bloodstream. Most commonly, this occurs when blood comes into contact with artificial surfaces, such as during the use of extracorporeal circulation devices or in patients with prosthetic heart valves.
Main pathogenetic mechanisms
The pathogenesis of decreased platelet count is multifaceted. Depending on the etiology, four leading mechanisms for the development of this pathology are distinguished:
- Increased splenic sequestration. Normally, this organ stores only a fraction of the cells. However, in splenomegaly (pathological enlargement of the spleen), sequestration increases sharply, leading to the development of distribution thrombocytopenia. Causes of this condition include liver cirrhosis, portal hypertension, splenic tuberculosis, as well as various myeloproliferative disorders and storage diseases.
- Hypoplastic and aplastic hematopoiesis states. In this case, the pathogenesis is associated with irreversible changes in the thrombopoiesis process itself. The main diagnostic sign is a critically low number of megakaryocytes in the bone marrow. Clinically, this manifests as thrombocytopenia of varying severity.
- Dilutional thrombocytopenia. This mechanism is triggered by massive blood loss. As a result of massive replenishment of circulating blood volume, hemodilution occurs, causing the relative concentration of cellular elements to drop rapidly.
- Immune mechanism. It is based on pathological agglutination (clumping) and subsequent destruction of platelets. This process is initiated by the production of autoantibodies (against own tissues) or alloantibodies (against foreign antigens), as well as the negative impact of circulating immune complexes.
Laboratory diagnostics
To make an accurate diagnosis and determine the specific pathogenetic mechanism, a strict algorithm of laboratory tests is applied. The basic panel includes the following stages:
- Determination of the absolute platelet count in peripheral blood (looking for the diagnostic criterion — a decrease in the parameter below $150 \times 10^9$/L).
- Detailed assessment of the morphology and functional activity of circulating blood platelets.
- Examination of bone marrow punctate. The key task here is to assess the number and morphology of megakaryocytes, which reliably differentiates hematopoietic problems from peripheral cell destruction.
Briefly: answers to topical questions
What clinical manifestations are typical for hemorrhagic syndrome in thrombocytopenia?
Clinical manifestations of hemorrhagic syndrome in thrombocytopenia include various types of bleeding. Skin manifestations are observed in the form of single or generalized petechial rash and ecchymoses, as well as hemorrhages on mucous membranes. Spontaneous or post-traumatic bleeding occurs: epistaxis, gingival bleeding, menorrhagia, and metrorrhagia. Rare and severe manifestations include gastrointestinal bleeding, hematuria, and intracranial hemorrhages.
Which groups of medicinal drugs most frequently induce immune thrombocytopenia?
Drug hypersensitivity can trigger the immune mechanism of platelet destruction. Provoking drugs that cause pronounced thrombocytopenia up to pancytopenia include sulfonamides, indometacin, phenylbutazone, cytostatics, and hydrochlorothiazide.
For quick memorization of the four main mechanisms of platelet count reduction, use the acronym SIHR: - S — Sequestration (retention in the spleen during splenomegaly). - I — Immune mechanism (destruction by antibodies and complexes). - H — Hypoplasia and aplasia (bone marrow damage). - R — Reduction / dilution (hemodilution during massive blood loss).
Class and exam questions
What platelet level is considered the diagnostic criterion for thrombocytopenia?
The diagnosis is established when the absolute platelet count in peripheral blood drops below $150 \times 10^9$/L. This condition is classified as a coagulopathy.
What is distribution thrombocytopenia?
This is a condition that occurs in splenomegaly (e.g., against the background of liver cirrhosis, portal hypertension, or storage diseases). Due to enlargement of the spleen, increased platelet sequestration occurs within it, which reduces their count in the circulating blood.
How to differentiate immune platelet destruction from bone marrow aplasia?
The key method is bone marrow evaluation. In hypo- and aplastic states, a low number of megakaryocytes is detected, indicating irreversible changes in thrombopoiesis. The immune mechanism, on the other hand, is associated with the destruction of already circulating cells under the action of antibodies or immune complexes.
Why does thrombocytopenia occur during massive blood loss?
During massive bleeding, so-called dilutional thrombocytopenia develops. It is caused by hemodilution — dilution of blood when replacing lost fluid volume, which leads to a relative decrease in cell concentration.
What else to study on this topic
- Morphology and functions of normal platelets
- Pathogenesis of portal hypertension and liver cirrhosis as causes of splenomegaly
- Mechanisms of auto- and alloantibody formation against platelets
- Impact of uremia and severe liver diseases on the hemostasis system
- Hyperplastic and metaplastic processes in the bone marrow
Master the entire topic in the "Pathological Anatomy" course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on «Thrombocytopenias» and 4,414 more subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 153 video lessons on the subject
Other topics in Hematopoietic System Diseases
Free video lessons: pathological anatomyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.